ArticleJournal of clinical medicine2022

mTOR Inhibitor Treatment in Patients with Tuberous Sclerosis Complex Is Associated with Specific Changes in microRNA Serum Profile.

Bartłomiej Pawlik et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.